berberine has been researched along with 3-nitrotyrosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liang, B; Shirwany, N; Wang, Q; Zhang, M; Zhu, Y; Zou, MH | 1 |
Crnčević-Orlić, Z; Cvijanović, O; Domitrović, R; Mikelić, L; Pernjak-Pugel, E; Skoda, M | 1 |
2 other study(ies) available for berberine and 3-nitrotyrosine
Article | Year |
---|---|
Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2.
Topics: Acetyl-CoA Carboxylase; Aldehydes; AMP-Activated Protein Kinases; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Berberine; Blood Glucose; Cholesterol; Enzyme Activation; Humans; Intercellular Adhesion Molecule-1; Ion Channels; Mice; Mitochondrial Proteins; Phosphorylation; Plaque, Atherosclerotic; Protein Transport; Serine; Threonine; Transcription, Genetic; Triglycerides; Tyrosine; Uncoupling Protein 2; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2011 |
Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis.
Topics: Aldehydes; Animals; Apoptosis; Autophagy; Berberine; Blood Urea Nitrogen; Cisplatin; Creatinine; Cytochrome P-450 CYP2E1; Kidney; Male; Mice; Mice, Inbred BALB C; Nephritis; Oxidative Stress; Protective Agents; Tyrosine | 2013 |